Chain Drug Review - Nizatidine nod
October 28, 2002 -- Teva Pharmaceuticals USA has introduced nizatidine capsules USP. The product is AB rated and bioequivalent to Axid Pulvules (Eli Lilly and Co...
Journal of AOAC International - Validated stability-indicating methods for the determination of nizatidine in the presence of its sulfoxide derivative
January 1, 2008 -- Four new selective, precise, and accurate methods are described for the determination of nizatidine (NIZ) in the presence of its sulfoxide derivative...
JCNN News Summaries - Japan Corporate News Network - Zeria Pharmaceutical Brings Nizatidine-based OTC Gastrointestinal
June 15, 2005 -- Tokyo, June 15, 2005 - (JCN) - Zeria Pharmaceutical (TSE: 4559) announced on June 14 that it has launched Acinon Z, a new over-the- counter...
Business Wire - Mylan Receives Approval for Nizatidine Capsules
July 9, 2002 -- Business & Health/Medical Writers Mylan Laboratories Inc. (NYSE: MYL) announced today that the U.S. Food and Drug Administration (FDA) has...
Business Wire - Teva Announces Final Approval of Nizatidine Capsules
September 12, 2002 -- Business Editors & Health/Medical Writers JERUSALEM--(BUSINESS WIRE)--Sept. 12, 2002 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA)...
Business Wire - Eon Labs Receives Approval for Nizatidine Capsules, USP
July 8, 2002 -- Business Editors, Health/Medical Writers Eon Labs, Inc. (Nasdaq:ELAB) announced today that it received final approval for Nizatidine Capsules, USP...
American Family Physician - Nizatidine for prevention of postprandial heartburn
March 1, 1998 -- Nizatidine is a selective histamine [H.sub.2]-receptor antagonist that inhibits histamine-mediated gastric acid secretion. Dosages of 150 mg and 300...
Chemical Market Reporter - NIZATIDINE.(Watson Pharmaceuticals Inc developing nizatidine capsules)(Brief Article)
November 6, 2000 -- Watson Pharmaceuticals Inc. has received tentative approval from the FDA for its ANDA for nizatidine capsules USP, 150 mg and 300 mg. Nizatidine...
Behavioral Health Management - Nizatidine/Zyprexa Treatment Data.(schizophrenia treatment)
May 1, 2001 -- New data presented at The International Congress on Schizophrenia Research (ICSR) showed that the use of 300 mg of nizatidine twice daily reduced...
Pediatric Nursing - Phase III clinical trial enrollment underway for treatment of AXID® Oral Solution for infants suffering from GERD
March 1, 2007 -- Active enrollment is underway in a Phase III clinical trial sponsored by Braintree Laboratories, to study the safety and efficacy of AXID[R] 1...
